Arline buys REGN $300.8: Regeneron Pharmaceuticals Price Target Increased to $329.00 by Analysts at ...

Regeneron Pharmaceuticals Price Target Increased to $329.00 by Analysts at ... WKRB News - 1 hour ago Regeneron Pharmaceuticals Inc. logo Regeneron Pharmaceuticals (NASDAQ:REGN) had its price objective hosited by Goldman Sachs Group Inc. from $298.00 to $3 ... (more)

Patria, Telma, Kimberley, and Noel bought Regeneron Pharmaceuticals.

Date			Volume	Open	High	Low	Close
20.9.13	--	----	1821600	306.8	307.0	299.1	300.8
19.9.13	--	---	1045300	310.0	310.6	298.1	307.1
18.9.13	--	----	1265000	297.8	311.0	297.8	309.2
17.9.13	--	--	675200	294.6	298.4	291.1	296.6
16.9.13	---	---	834500	291.7	296.0	285.3	294.4
13.9.13	----	---	1008100	278.8	290.0	278.8	290.0
12.9.13	--		328700	277.0	278.8	272.2	273.6
11.9.13	---	-	474300	277.1	277.8	269.5	276.9
10.9.13	-	--	584700	279.8	279.9	275.3	276.6
9.9.13	---	--	804800	267.9	277.5	267.9	276.8
6.9.13	--	-	479000	270.0	270.1	261.8	267.6
5.9.13	-	--	602700	268.5	270.0	266.0	268.6
4.9.13	----	---	916200	258.9	269.1	255.0	268.2
3.9.13	----	---	919600	246.0	260.0	246.0	259.1
30.8.13	---	-	462300	243.1	244.3	237.9	242.3
29.8.13	---	--	606600	244.0	247.8	241.0	243.6
28.8.13	---	--	559900	239.9	243.5	235.0	243.1
27.8.13	--	--	677000	240.7	243.3	238.2	239.2
26.8.13	---	--	740400	239.0	246.6	238.0	245.0
23.8.13	--	-	485300	239.5	240.0	236.4	238.8

People viewing REGN also viewed: XLI CMCSA ABX PCLN AMGN ESRX MOS LBTYA

---

Regeneron Pharmaceuticals Inc (REGN) to Continue Growth with Ocular Drug ... The Wall Street Transcript - 1 hour ago “Look at Regeneron now and a lot of that growth, it certainly commands a premium valuation because of what we've been discussing, but ... (more)

---

Regeneron Pharmaceuticals Stock Rating Reaffirmed by TheStreet (REGN) WKRB News - 7 hours ago “Regeneron Pharmaceuticals (REGN) has been reiterated by TheStreet Ratings as a buy with a ratings score of B. The company's strengths can be seen in multip ... (more)

---

REGENERON PHARMACEUTICALS INC : Regeneron to Present Phase 3 Data ... (press release) - 11 hours ago TARRYTOWN, N.Y., Sept. 17, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that detailed results from the Pha ... (more)

---

Positive outlook of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by analyst ... KP Insider - Sep 13, 2013 Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has upgraded by RBC Capital Markets. Results for a new cholesterol-fighting treatment that Regeneron is dev ... (more)

---

You replied to an email that I sent to skip B. You didn't know the name of my dog. Please tell me about yourself, what your interests are, your family. You said that you like to garden and that your name is William Elliott. ... (more)

15 people are following Regeneron Pharmaceuticals
Charles,
Bonnie,
Wenona,
Cassy,
Nam,
Joie,
Emelina,
Tennille,
Sigrid,
Corrine,
Queenie,
Manuela,
Hilde,
Yukiko, and
Elvera